DrugPatentWatch Database Preview
METOPROLOL TARTRATE Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Metoprolol Tartrate patents expire, and when can generic versions of Metoprolol Tartrate launch?
Metoprolol Tartrate is a drug marketed by Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Luitpold, Mylan Asi, Sandoz Inc, Watson Labs, West-ward Pharms Int, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Heritage Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Yaopharma Co Ltd, Youngtech Pharms Inc, and Sun Pharm Inds. and is included in thirty-five NDAs.
The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for METOPROLOL TARTRATE
| US Patents: | 0 |
| Applicants: | 27 |
| NDAs: | 35 |
| Suppliers / Packagers: | 48 |
| Bulk Api Vendors: | 77 |
| Clinical Trials: | 16 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for METOPROLOL TARTRATE |
| Drug Sales Revenues: | Drug sales revenues for METOPROLOL TARTRATE |
| DailyMed Link: | METOPROLOL TARTRATE at DailyMed |
See drug prices for METOPROLOL TARTRATE
Recent Clinical Trials for METOPROLOL TARTRATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Qilu Hospital of Shandong University | N/A |
| Corcept Therapeutics | Phase 1 |
| Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Pharmacology for METOPROLOL TARTRATE
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Synonyms for METOPROLOL TARTRATE
| ( inverted question mark)-Metoprolol (+)-tartrate |
| (?)-Metoprolol (+)-tartrate |
| (?)-Metoprolol (+)-tartrate salt |
| ()1-(Isopropylamino)-3-[p-(beta-methoxyethyl)phenoxy]-2-propanol (+)-tartrate salt |
| (+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol hemi-L-tartrate |
| (+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol L-(+)-tartrate (2:1) (salt) |
| (+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol tartrate (2:1) |
| (+/-)-Metoprolol (+)-tartrate salt, >=98% (titration), powder |
| (+/-)-Metoprolol (+)-tartrate salt, analytical standard |
| (2R,3R)-2,3-Dihydroxybutanedioic acid--1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol (1/2) |
| (2R,3R)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol |
| (A+/-)-Metoprolol (+)-tartrate |
| (y)-Metoprolol (+)-tartrate |
| 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)-propan-2-ol 2,3-dihydroxysuccinate (2:1) |
| 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol 2,3-dihydroxysuccinate |
| 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol 2,3-dihydroxysuccinate (2 |
| 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol 2,3-dihydroxysuccinate (2:1) |
| 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) Dextro-tartrate salt |
| 1-(Isopropylamino)-3-(p-[beta-methoxyethyl]phenoxy)-2-propanol tartrate |
| 1-(Isopropylamino)-3-[4-(beta-methoxyethyl)phenoxy]-2-propanol (+)-Tartrate |
| 1-[4-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol hemitartrate |
| 1-Isopropylamino-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) dextro-tartrate salt |
| 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt) |
| 2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, tartrate (2:1) |
| 2-Propanol, 1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-, (+-)-, tartrate (2:1) |
| 2-Propanol, 1-[4-(2methoxyethyl)phenoxy)-3-[(1-methylethyl)amino]-, (+-)-, [R-(R*,R*)]-2,3-dihydroxy |
| 2543AH |
| 2C15H25NO3.C4H6O6 |
| 56392-17-7 |
| AB2000335 |
| AKOS015961630 |
| AKOS016002993 |
| AKOS025310917 |
| ANW-58344 |
| Apo-Metoprolol |
| Arbralene |
| AS-10163 |
| Azumetop |
| BCP12837 |
| Beloc |
| Beprolo |
| Bloksan |
| Bloxan |
| Cardoxone |
| CAS-56392-17-7 |
| CCG-220733 |
| CCG-222032 |
| CGP 2175E |
| CGP-2175E |
| CHEBI:6906 |
| CHEMBL2062335 |
| CHEMBL3186768 |
| CTK8B7746 |
| D00601 |
| DB-052906 |
| DSSTox_CID_17248 |
| DSSTox_GSID_37248 |
| DSSTox_RID_79315 |
| DTXSID9037248 |
| EINECS 260-148-9 |
| EU-0100728 |
| H 93/26 |
| HMS1570C08 |
| HMS2097C08 |
| HMS3262A18 |
| HMS3651I21 |
| HMS3714C08 |
| Jeprolol |
| Kapodine |
| KS-00000XQB |
| Lanoc |
| Lopac-M-5391 |
| LS-122402 |
| M 5391 |
| M2555 |
| Mepolol |
| Meto AbZ |
| Meto-Isis |
| Metoberag |
| Metoberta |
| Metocard |
| Metolol |
| Metomerck |
| Metop |
| Metoproferm |
| Metoprolin |
| Metoprolol acis |
| Metoprolol AL |
| Metoprolol Apogepha |
| Metoprolol Atid |
| Metoprolol Basics |
| Metoprolol hemitartrate |
| Metoprolol Heumann |
| Metoprolol PB |
| Metoprolol Stada |
| Metoprolol tartrate (2:1) |
| Metoprolol tartrate (JP17/USP) |
| Metoprolol Tartrate [USAN:JAN] |
| Metoprolol tartrate [USAN:USP:JAN] |
| Metoprolol Tartrate 1.0 mg/ml in Methanol (as free base) |
| Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
| Metoprolol tartrate, British Pharmacopoeia (BP) Reference Standard |
| Metoprolol tartrate, European Pharmacopoeia (EP) Reference Standard |
| Metoprolol Tartrate, Pharmaceutical Secondary Standard; Certified Reference Material |
| Metoprolol tartrate, United States Pharmacopeia (USP) Reference Standard |
| Metoprolol Verla |
| Metoprolol-(+,-) (+)-tartrate salt |
| Metoprolol-GRY |
| Metoprolol-radiopharm |
| Metoprolol-rpm |
| metoprolol-tartrate |
| Metoprolol-Wolf |
| MFCD00056257 |
| Minax |
| NCGC00016170-01 |
| NCGC00017119-01 |
| NCGC00021148-08 |
| NCGC00094074-01 |
| NCGC00094074-02 |
| NCGC00261413-01 |
| PMS-Metroprolol-B |
| Prelis |
| Prestwick_1009 |
| Proken M |
| Prolaken |
| Q-201402 |
| Q27292351 |
| rac Metoprolol Hemi (+)-Tartrate |
| Ritmolol |
| RTR-019802 |
| SCHEMBL1649321 |
| SCHEMBL2051655 |
| Selectadril |
| Selokeen |
| Selopral |
| Sigaprolol |
| Slow lopresor |
| Slow-Lopresor |
| SR-01000872674 |
| SR-01000872674-1 |
| ST24037610 |
| SW199199-2 |
| Topromel |
| Tox21_110787 |
| Tox21_110787_1 |
| Tox21_113528 |
| Tox21_500728 |
| Vasocardin |
US Patents and Regulatory Information for METOPROLOL TARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 200981-005 | Aug 21, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 073666-002 | Dec 21, 1993 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Teva | METOPROLOL TARTRATE | metoprolol tartrate | TABLET;ORAL | 074143-001 | Sep 30, 1994 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Alembic Pharms Ltd | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; metoprolol tartrate | TABLET;ORAL | 202870-001 | Nov 6, 2013 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
